INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 221
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Rx Pros

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

Homepage price cards: 'Now only $149' (was $249).

Audienceread

Read: weight-loss telehealth consumer.

Pricing & termssnapshot

Multiple live quotes: sema $149 intro/$134.99 comparison/$99.99 annual floor; tirz $249/$224.99/$144.97. Campaigns conflict.

Clinical relationshipspartial

Board-certified doctors advertised, but current terms do not establish named treating medical group.

Pharmacy & fulfillmentpartial

503A/503B partners advertised; specific current pharmacies not established. Patient may request own pharmacy before completing order.

Advertising snapshotsnapshot

US last-30-days domain lookup, 15 Oct 2026: about 200 ads. Advertiser labels: Rx Pros LLC. Counter/grid inconsistencies and historical retained cards are not active-ad or spend proof. US active exact-keyword lookup, 15 Oct 2026: No match for Rx Pros; RxPros returns two Weekly Reading Recap earbud ads pointing to quiz.rxpros.com (IDs1388359166208661 and1905172457128597).

Founding yearnot_found

Not established from reviewed free public sources as of 15 Oct 2026.

    Foundersnot_found

    Not established from reviewed free public sources as of 15 Oct 2026.

      Location & entity contextnot_found

      Not established from reviewed free public sources as of 15 Oct 2026.

        Search visibility samplesnapshot

        Public search snapshot, 15 Oct 2026: Personalized Medication Information; Semaglutide; Rx Pros; Tirzepatide. Free site-restricted discovery only; search ranking, traffic, volume and authority are not measured.

        THE MODERN DOSING WEEKLY

        The peptide news
        that changes your week.

        Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.